/VBIO

VBIO Stock - Malachite Innovations, Inc.

Q: What is the analyst price target for VBIO?

Analyst price target information is not currently available for VBIO.

Q: What is VBIO's market cap?

Market capitalization information is not currently available for VBIO.

Healthcare|Biotechnology|OTC

$0.39+11.43%

+$0.04 (+11.43%) • Apr 24

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.43

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for VBIO

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2017

FY2018

FY2019

FY2020

FY2021

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta4.11

52W High$0.85

52W Low$0.05

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2021	FY2020	FY2019	FY2018	FY2017
Revenue	N/A	N/A	N/A	$102,420	$163,360
Gross Profit	N/A	N/A	N/A	$24,480	$55,100
Gross Margin	N/A	N/A	N/A	23.9%	33.7%
Operating Income	$-2,338,213	$-3,692,710	$-4,566,820	$-4,396,750	$-3,471,550
Net Income	$-880,851	$-4,365,360	$-20,136,570	$-4,309,000	$-5,219,380
Net Margin	N/A	N/A	N/A	-4207.2%	-3195.0%
EPS	$-0.02	$-0.09	$-0.61	$-0.19	$-0.38

Company Overview

Vitality Biopharma, Inc. engages in the development of cannabinoid pharmaceuticals for the treatment of inflammatory disorders in the United States. The company is developing tetrahydrocannabinol glycoside (VBX-100), an oral cannabinoid prodrug for inflammatory bowel disease and irritable bowel syndromes. The company was formerly known as Stevia First Corp. and changed its name to Vitality Biopharma, Inc. in July 2016. Vitality Biopharma, Inc. was founded in 2007 and is headquartered in Los Angeles, California.

Visit Website

Frequently Asked Questions about VBIO

What is VBIO's current stock price?

Malachite Innovations, Inc. (VBIO) is currently trading at $0.39 per share. The stock has moved +11.43% today.

What is the analyst price target for VBIO?

No analyst price targets are currently available for this stock.

What sector is Malachite Innovations, Inc. in?

Malachite Innovations, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.

What is VBIO's market cap?

Malachite Innovations, Inc. has a market capitalization of N/A, making it a small-cap company.

Does VBIO pay dividends?

No, Malachite Innovations, Inc. does not currently pay a dividend to shareholders.